The Lancefield International Symposium on Streptococci and Streptococcal Diseases (LISSSD) serves as a global platform for Queensland’s pioneering research, leading to human vaccine trials targeting Strep A, which is accountable for over 500,000 deaths worldwide annually. Scheduled for June 2025, …